Clinical Trial Update: DJ-927 as Second-Line Therapy in Treating Patients With Progressive Locally Advanced or Metastatic Colorectal Adenocarcinoma [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 trial evaluating DJ-927 as a second-line treatment for progressive locally advanced or metastatic colorectal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• DJ-927

Snippet

Sponsor: Daiichi Sankyo | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED